
Opinion|Videos|June 10, 2024
Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management
Author(s)Kristine Kucera, PA-C, MPAS, DHS , Mickey Bryson
Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
4
Social Media Mythbusters: The Summer Skin Care "Shutdown"
5














